Treatment of multiple sclerosis

Multiple sclerosis is treated by reducing the fluid pressure in the myelin sheath of nerves to reduce or prevent bursting of the sheath. Prostaglandins are the preferred agent for achieving a reduction in the pressure.

Saved in:
Bibliographic Details
Main Author COLOVER JACK
Format Patent
LanguageEnglish
Published 10.01.2002
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Multiple sclerosis is treated by reducing the fluid pressure in the myelin sheath of nerves to reduce or prevent bursting of the sheath. Prostaglandins are the preferred agent for achieving a reduction in the pressure.
Bibliography:Application Number: US20010877118